Viveve Medical Inc EV/EBIT
Was ist das EV/EBIT von Viveve Medical Inc?
EV/EBIT von Viveve Medical Inc ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Viveve Medical Inc
Was macht Viveve Medical Inc?
viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.
Unternehmen mit ev/ebit ähnlich Viveve Medical Inc
- Digital Landscape hat EV/EBIT von N/A
- Immunome hat EV/EBIT von N/A
- Royal BAM Groep NV hat EV/EBIT von N/A
- CURO Corp hat EV/EBIT von N/A
- Adial Pharmaceuticals hat EV/EBIT von N/A
- NuZee hat EV/EBIT von N/A
- Viveve Medical Inc hat EV/EBIT von N/A
- Syros Pharmaceuticals hat EV/EBIT von N/A
- Minerva Intelligence hat EV/EBIT von N/A
- windeln.de SE hat EV/EBIT von N/A
- Smith Micro Software hat EV/EBIT von N/A
- Viaan Industries hat EV/EBIT von N/A
- Lantern Pharma hat EV/EBIT von N/A